Introduction: The Small Business Innovation Research (SBIR) and Small Business Tech Transfer (STTR) programs are congressionally-mandated programs that allow federal agencies to fund promising technologies that fulfill their missions. SBIR/STTR grants through the NIH and NSF are a valuable resource to academic pharmacologists and early-stage entrepreneurs looking to bring their new therapeutics to the market. This panel will feature NIH and NSF program staff, SBIR/STTR awardees, and reviewers who have served on SBIR/STTR study sections and provide information for pharmacologists who are interested in pursuing these opportunities.
Elizabeth Sharlow ( University of Virginia/KeViRx )
